Clinical trials
Not yet recruiting Sarcoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 1 |
| 2024 | 8 |
| 2025 | 8 |
| 2026 | 28 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 50 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 3 |
| Advenchen Pharmaceuticals, LLC. | 2 |
| Fudan University | 2 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 2 |
| Shenzhen Geno-Immune Medical Institute | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Adam Olson | 1 |
| Andrew Frankart | 1 |
| Beijing Biostar Pharmaceuticals Co., Ltd. | 1 |
| Centre Leon Berard | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcoma | 50 |
| Neoplasms | 4 |
| Osteosarcoma | 4 |
| Bone Neoplasms | 3 |
| Breast Neoplasms | 3 |
| Endometrial Neoplasms | 3 |
| Sarcoma, Ewing | 3 |
| Liposarcoma | 2 |
| Lung Neoplasms | 2 |
| Melanoma | 2 |
Trials
Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.